Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 2740619)

Published in Circ Res on September 26, 2008

Authors

Deborah A McDermott, Cathy J Hatcher, Craig T Basson

Articles by these authors

Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 4.34

Mutation of perinatal myosin heavy chain associated with a Carney complex variant. N Engl J Med (2004) 4.22

Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88

Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science (2004) 2.53

Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol (2008) 1.76

Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2006) 1.68

TBX5 nuclear localization is mediated by dual cooperative intramolecular signals. J Mol Cell Cardiol (2003) 1.67

Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation (2007) 1.59

Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A (2004) 1.56

TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res (2005) 1.38

Impact of image analysis methodology on diagnostic and surgical classification of patients with thoracic aortic aneurysms. Ann Thorac Surg (2011) 1.32

Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol (2004) 1.27

A role for Tbx5 in proepicardial cell migration during cardiogenesis. Physiol Genomics (2004) 1.21

Inherited disposition to cardiac myxoma development. Nat Rev Cancer (2006) 1.18

The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from phase I and scientific opportunities in phase II. Am Heart J (2011) 1.17

Clinical phenotypes and molecular genetic mechanisms of Carney complex. Lancet Oncol (2005) 1.14

Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann Thorac Surg (2009) 1.06

Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation (2013) 1.01

Haploinsufficiency at the protein kinase A RI alpha gene locus leads to fertility defects in male mice and men. Mol Endocrinol (2006) 1.00

Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management. Genet Med (2008) 0.98

The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol (2010) 0.96

Specification of the cardiac conduction system by transcription factors. Circ Res (2009) 0.96

A KCNE2 mutation in a patient with cardiac arrhythmia induced by auditory stimuli and serum electrolyte imbalance. Cardiovasc Res (2007) 0.92

Sparking the failing heart. N Engl J Med (2004) 0.91

Transcription factor cascades in congenital heart malformation. Trends Mol Med (2003) 0.91

High-risk patients with ventricular preexcitation--a pendulum in motion. N Engl J Med (2003) 0.90

TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction. Circ Cardiovasc Genet (2012) 0.86

Preimplantation genetic diagnosis of human congenital heart malformation and Holt-Oram syndrome. Am J Med Genet A (2004) 0.82

Update: PGD and Holt-Oram syndrome. Am J Med Genet A (2005) 0.81

Impact of genetic insights into mendelian disease on cardiovascular clinical practice. Circulation (2011) 0.81

Keratin gene expression profiles after digit amputation in C57BL/6 vs. regenerative MRL mice imply an early regenerative keratinocyte activated-like state. Physiol Genomics (2013) 0.81

Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (2003) 0.78

Disrupted intercalated discs. Is kindlin-2 required? Circ Res (2008) 0.78

Degenerating heart valves: fill them up with filamin? Circulation (2007) 0.78

The carney complex: unusual skin findings and recurrent cardiac myxoma. Arch Dermatol (2005) 0.78

Using the TBX5 transcription factor to grow and sculpt the heart. Am J Med Genet A (2006) 0.77

Treatment goals for the management of lipids and inflammation for patients with coronary artery disease. Curr Treat Options Cardiovasc Med (2007) 0.76

Can genetic testing improve our aim in hypertrophic cardiomyopathy? Circ Res (2010) 0.76

Modeling development of the epicardium and coronary vasculature: in vitro veritas? Circ Res (2003) 0.75

Taking a bite out of hypertrophic cardiomyopathy: soy diet and disease. J Clin Invest (2006) 0.75

Genetics of cardiac septation defects and their pre-implantation diagnosis. Methods Mol Med (2006) 0.75

Structural and functional genetic disorders of the great vessels and outflow tracts. Ann N Y Acad Sci (2006) 0.75